1. Home
  2. MBIO vs MLEC Comparison

MBIO vs MLEC Comparison

Compare MBIO & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.73

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$7.23

Market Cap

5.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIO
MLEC
Founded
2015
2008
Country
United States
Cayman Islands
Employees
N/A
72
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
5.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MBIO
MLEC
Price
$0.73
$7.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.6K
225.1K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
98.99
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.42
Revenue Next Year
N/A
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.21
52 Week High
$7.00
$23.22

Technical Indicators

Market Signals
Indicator
MBIO
MLEC
Relative Strength Index (RSI) 43.98 45.00
Support Level $0.71 $7.00
Resistance Level $1.00 $12.38
Average True Range (ATR) 0.05 1.15
MACD 0.01 -0.03
Stochastic Oscillator 67.98 28.66

Price Performance

Historical Comparison
MBIO
MLEC

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

Share on Social Networks: